Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3203169/?toolubmed
Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22127371
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/21603976
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CBâ‚- and FAAH-independent mechanisms (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687660/
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25460026
Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22127371
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/21603976
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CBâ‚- and FAAH-independent mechanisms (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687660/
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25460026